Chronic atrial fibrillation in patients with paroxysmal atrial fibrillation, atrioventricular node ablation and pacemakers: Determinants and treatment

Europace

Volumn 1, Issue 1, 1999, Pages 30-34

  McComb, J M ^a   Gribbin, G M ^a  

^a FREEMAN HOSPITAL   (United Kingdom)

Author keywords

Atrial fibrillation; Atrioventricular node ablation; DDD; Paroxysmal; Permanent pacemaker; Stroke; VVI

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIOVERSION; CATHETER ABLATION; CEREBROVASCULAR ACCIDENT; CHRONIC DISEASE; ELECTROCARDIOGRAPHY; FEMALE; HEART ATRIOVENTRICULAR NODE; HEART ATRIUM FIBRILLATION; HUMAN; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDY; RISK FACTOR;

ANTICOAGULANTS; ATRIAL FIBRILLATION; ATRIOVENTRICULAR NODE; CATHETER ABLATION; CEREBROVASCULAR ACCIDENT; CHRONIC DISEASE; COMBINED MODALITY THERAPY; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PACEMAKER, ARTIFICIAL; RETROSPECTIVE STUDIES; RISK FACTORS; WARFARIN;

EID: 0032601087     PISSN: 10995129     EISSN: None     Source Type: Journal    
DOI: 10.1053/eupc.1998.0009     Document Type: Article

References (17)

1. Sutton R, Kenny RA. The natural history of sick sinus syndrome. PACE 1986; 9: 1110-14.
2. Hesselson AB, Parsonnet V, Bernstein AD, Bonavita GJ. Deleterious effects of long term single chamber ventricular pacing in patients with sick sinus syndrome: the hidden benefits of dual chamber pacing. J Am Coll Cardiol 1992; 19: 1542-9.
3. Sgarbossa EB, Pinski SL, Maloney JD et al. Chronic atrial fibrillation and stroke in paced patients with sick sinus syndrome. Relevance of clinical characteristics and pacing modalities. Circulation 1993; 88: 1045-53.
4. Lamas GA. Pacemaker mode selection and survival: a plea to apply the principles of evidence based medicine to cardiac pacing practice. Heart 1997; 78: 224-5.
5. Andersen HR, Thuesen L, Bagger JP, Vesterlund T, Bloch Thomsen PE. Prospective randomised trial of atrial versus ventricular pacing in sick sinus syndrome. Lancet 1994; 344: 1523-8.
6. Andersen HR, Nielsen JC, Bloch Thomsen PE et al. Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet 1997; 350: 1210-6.
7. Gross JN, Moser S, Benedek ZM, Benedek ZM, Andrews C, Furman S. DDD pacing mode survival in patients with a dual-chamber pacemaker. J Am Coll Cardiol 1992; 19: 1536-41.
8. Aboaf AP, Wolf PS. Paroxysmal atrial fibrillation A common but neglected entity. Arch Int Med 1996; 156: 362-7.
9. Mitchell MA, Ackerman SJ, Nath S, Haines DE, DiMarco JP. Atrial rhythm after atrioventricular junctional ablation. Am J Cardiol 1996; 78: 1251-4.
10. Kannel W, Abbott R, Savage D, McNamara P. Epidemiological features of atrial fibrillation. The Framingham Study. N Engl J Med 1982; 306: 1018-22.
11. Cresswell LL, Schuessler RB, Rosenbloom M, Cox JL. Hazards of postoperative atrial arrhythmias. Ann Thorac Surg 1993; 56: 539-49.
12. Brignole M, Gianfranchi L, Menozzi C et al. Assessment of atrioventricular junction ablation and DDDR mode switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation A randomized controlled study. Circulation 1997; 96: 2617-24.
13. Feuer JM, Shandling AH, Messenger JC. Influence of cardiac pacing mode on the long-term development of atrial fibrillation. Am J Cardiol 1989; 64: 1376-9.
14. Brandt J, Anderson H, Fåhraeus T, Schüller H. Natural history of sinus node disease treated with atrial pacing in 213 patients: implications for selection of stimulation mode. J Am Coll Cardiol 1992; 20: 633-9.
15. Sopher SM, Camm AJ. Atrial fibrillation: maintenance of sinus rhythm versus rate control. Am J Cardiol 1996; 77: 24A-37A.
16. Stroke Prevention in Atrial Fibrillation Investigators. Stroke Prevention in Atrial Fibrillation Study: Final results. Circulation 1991; 84: 527-39.
17. Flaker GC, Blackshear JL, McBride R, Kronmal RA, Halperin JL, Hart RG, on behalf of the Stroke Prevention in Atrial Fibrillation Investigators. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. Circulation 1992; 20: 527-32.